The cost of developing a new drug – a process that can take between 10 and 15 years from concept to market – has risen…
April 20, 2024
As Tesla, Inc. (TSLA) continues to report dismal numbers and news, an ominous tone is being set for the EV market as most of the…
April 13, 2024
Advancing Vaccines for Cancer
Cancer was responsible for nearly 10 million deaths in 2020. Treatments for cancer, which represents a group of complex and diverse diseases, have been in…
If you are not a pet person and it’s not allergy related, we’d like to know what UFO you’re reading this from. Because who doesn’t…
As March Madness moves into the Final Four, some degenerate gamblers, sports aficionados or both are still looking to capitalize on their bracket pools. Saturday…
March 23, 2024
The Next Blockbuster? FDA Approvals in 2024
Drug development is an arduous, costly and time-consuming process for the teams involved behind the scenes, and the patients anxiously awaiting breakthroughs in different disease…
March 20, 2024
Stock Picks That Could Make Barry Manilow Think You Raid His Wardrobe – A Breakfast Club Edition
In today’s world of AI and technology, there are some memories of the past that still hold a true nostalgia for the more simplistic times…
This week, Madrigal Therapeutics (Nasdaq: MDGL) won FDA approval for Rezdiffra™, the first and only drug to be approved for metabolic dysfunction-associated steatohepatitis (MASH). The…
Ibogaine, a potent psychedelic derived from the root of a Central African shrub, is making headlines for its potential to revolutionize the treatment of opioid…
February 28, 2024
Bone Cancer: Rare Disease Taking a Share of the Biotech Spotlight
Bone cancer is rare, making up just one percent of all cancer cases. Despite advances in treatment for other cancers, the standard of care for…
February 20, 2024
AI Companies Shaping Tomorrow: A Jetsons-Worthy Portfolio Selection
Artificial Intelligence or “AI” seems to be the new, hot two letter word on everybody’s lips. If you’re a CEO mentioning AI on an earnings…
The FDA has approved the first new frontline treatment for metastatic pancreatic cancer in more than a decade. This week, global biopharmaceutical company, Ipsen, announced…